insulin glargine-yfgn
insulin glargine-yfgn is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand names including SEMGLEE, INSULIN GLARGINE. Available dosage form: injection, solution.
Drug Details
- Generic Name
- insulin glargine-yfgn
- Brand Names
- SEMGLEE, INSULIN GLARGINE
- Application Number
- BLA761201
- Sponsor
- Biocon Biologics Inc.
- NDC Codes
- 4
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- INSULIN GLARGINE
Indications and Usage
1 INDICATIONS AND USAGE Insulin Glargine-yfgn is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. Limitations of Use Insulin Glargine-yfgn is not recommended for the treatment of diabetic ketoacidosis. Insulin Glargine-yfgn is a long-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 ) Limitations of Use Not recommended for the treatment of diabetic ketoacidosis. ( 1 )